0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 21-40 of 742 Articles
JAMA | 
JAMA Diagnostic Test Interpretation | 
Talal Hilal, MD; Edward H. Romond, MD
JAMA. 2016;315(12):1280-1281. doi:10.1001/jama.2015.17463.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Elizabeth A. Mittendorf, MD, PhD; Jose Vila, MD; Susan L. Tucker, PhD; et al.
JAMA Oncol. Published online March 17, 2016. doi:10.1001/jamaoncol.2015.6478
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Scott F. Huntington, MD, MPH, MSHP; Cary P. Gross, MD
JAMA Oncol. Published online March 10, 2016. doi:10.1001/jamaoncol.2015.6540

JAMA | 
Viewpoint | 
Kenneth W. Lin, MD, MPH; Lawrence O. Gostin, JD
JAMA. 2016;315(10):977-978. doi:10.1001/jama.2016.0322.

JAMA Oncology | 
From The JAMA Network | 
Lesley Fallowfield, BSc, DPhil; Adele Francis, MB, ChB, FRCS, PhD
JAMA Oncol. 2016;2(3):382-383. doi:10.1001/jamaoncol.2015.5026.

JAMA Oncology | 
Original Investigation | 
Mariana Chavez-MacGregor, MD, MSc; Christina A. Clarke, PhD, MPH; Daphne Y. Lichtensztajn, MD, MPH; et al.
JAMA Oncol. 2016;2(3):322-329. doi:10.1001/jamaoncol.2015.3856.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Richard J. Bleicher, MD; Karen Ruth, MS; Elin R. Sigurdson, MD, PhD; et al.
JAMA Oncol. 2016;2(3):330-339. doi:10.1001/jamaoncol.2015.4508.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Adrienne G. Waks, MD; Tari A. King, MD; Eric P. Winer, MD
JAMA Oncol. 2016;2(3):302-304. doi:10.1001/jamaoncol.2015.4506.

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Veerle Bossuyt, MD; Christos Hatzis, PhD
JAMA Oncol. Published online February 25, 2016. doi:10.1001/jamaoncol.2015.6509

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Kristine R. Broglio, MS; Melanie Quintana, PhD; Margaret Foster, MS; et al.
JAMA Oncol. Published online February 25, 2016. doi:10.1001/jamaoncol.2015.6113
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Nehmat Houssami, MBBS, FAFPHM, PhD; Diana L. Miglioretti, PhD
JAMA Oncol. Published online February 18, 2016. doi:10.1001/jamaoncol.2015.5569

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Brian J. Zikmund-Fisher, PhD; Nancy K. Janz, PhD; Sarah T. Hawley, PhD, MPH; et al.
JAMA Oncol. Published online February 18, 2016. doi:10.1001/jamaoncol.2015.6416

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Elizabeth S. McDonald, MD, PhD; Andrew Oustimov, MPH; Susan P. Weinstein, MD; et al.
JAMA Oncol. Published online February 18, 2016. doi:10.1001/jamaoncol.2015.5536
Includes: Supplemental Content

JAMA Surgery | 
Invited Commentary |  ONLINE FIRST
Uttara Nag, MD; E. Shelley Hwang, MD, MPH
JAMA Surg. Published online February 17, 2016. doi:10.1001/jamasurg.2015.5555

JAMA Surgery | 
Original Investigation |  ONLINE FIRST
Abby J. Isaacs, MS; Mary L. Gemignani, MD, MPH; Andrea Pusic, MD, MHS, FRCSC; et al.
JAMA Surg. Published online February 17, 2016. doi:10.1001/jamasurg.2015.5535
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Kathleen R. Blazer, EdD, MS, LCGC; Thomas Slavin, MD; Jeffrey N. Weitzel, MD
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.5975

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Shoshana M. Rosenberg, ScD, MPH; Kathryn J. Ruddy, MD, MPH; Rulla M. Tamimi, ScD; et al.
JAMA Oncol. Published online February 11, 2016. doi:10.1001/jamaoncol.2015.5941
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint | 
Teresa K. Woodruff, PhD; Kristin Smith, BS; William Gradishar, MD
JAMA Oncol. 2016;2(2):171-172. doi:10.1001/jamaoncol.2015.5609.

JAMA Oncology | 
Research Letter | 
Jordan D. Lane, MD; Mark W. Friedberg, MD, MPP; Charles L. Bennett, MD, PhD, MPP
JAMA Oncol. 2016;2(2):274-276. doi:10.1001/jamaoncol.2015.3928.

JAMA Oncology | 
Invited Commentary | 
David Warr, MD, FRCPC; Carlo DeAngelis, PharmD; Edward Chow, MBBS
JAMA Oncol. 2016;2(2):232-233. doi:10.1001/jamaoncol.2015.3757.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts
Elizabeth A. Rafferty, MD; Melissa A. Durand, MD; Emily F. Conant, MD; et al.
JAMA Oncology
Invited Commentary  | 
Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer
Anne F. Schott, MD
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HERA Trial
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.